• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗朊病毒蛋白适体的开发与结构鉴定及其对朊病毒蛋白病理性构象转换的阻断作用。

Development and structural determination of an anti-PrP aptamer that blocks pathological conformational conversion of prion protein.

机构信息

Institute of Advanced Energy, Kyoto University, Kyoto, 611-0011, Japan.

Graduate School of Energy Science, Kyoto University, Kyoto, 611-0011, Japan.

出版信息

Sci Rep. 2020 Mar 18;10(1):4934. doi: 10.1038/s41598-020-61966-4.

DOI:10.1038/s41598-020-61966-4
PMID:32188933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7080826/
Abstract

Prion diseases comprise a fatal neuropathy caused by the conversion of prion protein from a cellular (PrP) to a pathological (PrP) isoform. Previously, we obtained an RNA aptamer, r(GGAGGAGGAGGA) (R12), that folds into a unique G-quadruplex. The R12 homodimer binds to a PrP molecule, inhibiting PrP-to-PrP conversion. Here, we developed a new RNA aptamer, r(GGAGGAGGAGGAGGAGGAGGAGGA) (R24), where two R12s are tandemly connected. The 50% inhibitory concentration for the formation of PrP (IC) of R24 in scrapie-infected cell lines was ca. 100 nM, i.e., much lower than that of R12 by two orders. Except for some antibodies, R24 exhibited the lowest recorded IC and the highest anti-prion activity. We also developed a related aptamer, r(GGAGGAGGAGGA-A-GGAGGAGGAGGA) (R12-A-R12), IC being ca. 500 nM. The structure of a single R12-A-R12 molecule determined by NMR resembled that of the R12 homodimer. The quadruplex structure of either R24 or R12-A-R12 is unimolecular, and therefore the structure could be stably formed when they are administered to a prion-infected cell culture. This may be the reason they can exert high anti-prion activity.

摘要

朊病毒病是一种致命的神经病变,由朊病毒蛋白从细胞型(PrPC)转化为病理性(PrPSc)异构体引起。此前,我们获得了一种 RNA 适体 r(GGAGGAGGAGGA)(R12),它折叠成独特的 G-四链体。R12 同源二聚体与 PrP 分子结合,抑制 PrP 向 PrPSc 的转化。在此,我们开发了一种新的 RNA 适体 r(GGAGGAGGAGGAGGAGGAGGAGGA)(R24),其中两个 R12 串联连接。R24 在感染瘙痒病的细胞系中形成 PrP 的 50%抑制浓度(IC)约为 100 nM,即比 R12 低两个数量级。除了一些抗体外,R24 表现出记录到的最低 IC 和最高抗朊病毒活性。我们还开发了一种相关的适体 r(GGAGGAGGAGGA-A-GGAGGAGGAGGA)(R12-A-R12),IC 约为 500 nM。通过 NMR 确定的单个 R12-A-R12 分子的结构类似于 R12 同源二聚体的结构。R24 或 R12-A-R12 的四链体结构都是单分子的,因此当它们被施用于感染朊病毒的细胞培养物时,可以稳定形成结构。这可能是它们能够发挥高抗朊病毒活性的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/bb6501638271/41598_2020_61966_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/bffbc8fa3226/41598_2020_61966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/dea462708458/41598_2020_61966_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/c8ff0fb87551/41598_2020_61966_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/8f4c723d98d4/41598_2020_61966_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/d5de236d02de/41598_2020_61966_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/bb6501638271/41598_2020_61966_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/bffbc8fa3226/41598_2020_61966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/dea462708458/41598_2020_61966_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/c8ff0fb87551/41598_2020_61966_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/8f4c723d98d4/41598_2020_61966_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/d5de236d02de/41598_2020_61966_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/7080826/bb6501638271/41598_2020_61966_Fig6_HTML.jpg

相似文献

1
Development and structural determination of an anti-PrP aptamer that blocks pathological conformational conversion of prion protein.抗朊病毒蛋白适体的开发与结构鉴定及其对朊病毒蛋白病理性构象转换的阻断作用。
Sci Rep. 2020 Mar 18;10(1):4934. doi: 10.1038/s41598-020-61966-4.
2
Anti-prion activity of an RNA aptamer and its structural basis.抗朊病毒活性的 RNA 适体及其结构基础。
Nucleic Acids Res. 2013 Jan;41(2):1355-62. doi: 10.1093/nar/gks1132. Epub 2012 Nov 24.
3
Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein.一种针对牛朊病毒蛋白的RNA适配体的独特四重结构及相互作用。
Nucleic Acids Res. 2009 Oct;37(18):6249-58. doi: 10.1093/nar/gkp647. Epub 2009 Aug 7.
4
In vitro selection of RNA aptamers against cellular and abnormal isoform of mouse prion protein.针对小鼠朊病毒蛋白的细胞型和异常异构体的RNA适配体的体外筛选。
Nucleic Acids Symp Ser (Oxf). 2005(49):361-2. doi: 10.1093/nass/49.1.361.
5
DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity.与PrP(C)而非PrP(Sc)结合的DNA适配体表现出序列和结构特异性。
Exp Biol Med (Maywood). 2006 Feb;231(2):204-14. doi: 10.1177/153537020623100211.
6
The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.抗朊病毒 RNA 适体 R12 破坏了朊病毒与淀粉样β之间与阿尔茨海默病相关的复合物。
FEBS J. 2019 Jun;286(12):2355-2365. doi: 10.1111/febs.14819. Epub 2019 Apr 8.
7
Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.高亲和力 DNA 适体调控朊病毒蛋白液-液相分离和纤维形成。
FASEB J. 2020 Jan;34(1):365-385. doi: 10.1096/fj.201901897R. Epub 2019 Nov 22.
8
Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.一种新型体外筛选技术在分离和鉴定与哺乳动物朊病毒蛋白结合的高亲和力DNA适配体中的应用。
J Virol Methods. 2008 Jul;151(1):107-15. doi: 10.1016/j.jviromet.2008.03.013. Epub 2008 Apr 23.
9
Transition of the prion protein from a structured cellular form (PrP ) to the infectious scrapie agent (PrP ).朊病毒蛋白从结构细胞形式(PrP)到传染性瘙痒病剂(PrP)的转变。
Protein Sci. 2019 Dec;28(12):2055-2063. doi: 10.1002/pro.3735. Epub 2019 Oct 25.
10
Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP.二硫键交联扫描揭示了朊病毒诱导的病理性朊病毒蛋白 PrP 的构象变化和朊病毒株特异性结构。
J Biol Chem. 2018 Aug 17;293(33):12730-12740. doi: 10.1074/jbc.RA117.001633. Epub 2018 Jun 22.

引用本文的文献

1
Direct Modeling of DNA and RNA Aptamers with AlphaFold 3: A Promising Tool for Predicting Aptamer Structures and Aptamer-Target Interactions.使用AlphaFold 3对DNA和RNA适配体进行直接建模:预测适配体结构和适配体-靶标相互作用的有前景工具。
ACS Synth Biol. 2025 Jul 3. doi: 10.1021/acssynbio.5c00196.
2
Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research.单域抗体和适体为神经退行性疾病研究带来新机遇。
Front Immunol. 2024 Aug 22;15:1426656. doi: 10.3389/fimmu.2024.1426656. eCollection 2024.
3
Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development.
适体技术在神经科学、神经诊断和神经医学发展中的应用。
Molecules. 2024 Mar 2;29(5):1124. doi: 10.3390/molecules29051124.
4
Structural Insights into Protein-Aptamer Recognitions Emerged from Experimental and Computational Studies.从实验和计算研究中揭示出蛋白-适体识别的结构见解。
Int J Mol Sci. 2023 Nov 14;24(22):16318. doi: 10.3390/ijms242216318.
5
Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.针对淀粉样蛋白的适体及其在神经退行性疾病中的新兴作用。
J Biol Chem. 2022 Jan;298(1):101478. doi: 10.1016/j.jbc.2021.101478. Epub 2021 Dec 9.
6
Beyond G-Quadruplexes-The Effect of Junction with Additional Structural Motifs on Aptamers Properties.超越 G-四链体-连接其他结构模体对适体性质的影响。
Int J Mol Sci. 2021 Sep 14;22(18):9948. doi: 10.3390/ijms22189948.
7
Harnessing the Physiological Functions of Cellular Prion Protein in the Kidneys: Applications for Treating Renal Diseases.利用肾脏中细胞朊病毒蛋白的生理功能:治疗肾脏疾病的应用。
Biomolecules. 2021 May 22;11(6):784. doi: 10.3390/biom11060784.
8
The emerging structural complexity of G-quadruplex RNAs.G-四链体 RNA 的新兴结构复杂性。
RNA. 2021 Apr;27(4):390-402. doi: 10.1261/rna.078238.120. Epub 2021 Jan 22.
9
The role of prion strain diversity in the development of successful therapeutic treatments.朊病毒毒株多样性在成功研发治疗方法中的作用。
Prog Mol Biol Transl Sci. 2020;175:77-119. doi: 10.1016/bs.pmbts.2020.07.001. Epub 2020 Aug 28.
10
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-7.药物化学的突破:新靶点与新机制、新药、新希望-7.
Molecules. 2020 Jun 28;25(13):2968. doi: 10.3390/molecules25132968.